Skip to content
Biodatica
Start free

Suzhou Alphamab Co., Ltd.

Shanghai, Shanghai Municipality

OncologyADCPhase II
Compare Sign in to watch

What changed

Phase II trial registered: Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma

3mo agoTrial registeredApr 2, 2026Source filing (opens the source filing in a new tab)

Momentum

69no change

Momentum 69 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

995 pre-ticker oncology companies at Phase II

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE2 registered

    Apr 1, 2026

    ctDNA, Gastric Cancer, Gastroesophageal Junction (GEJ) Adenocarcinoma, Adjuvant Treatment · NOT_YET_RECRUITING · sponsor: Fudan University · Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma

    ClinicalTrials.gov · NCT07507916 (opens the source filing in a new tab)

  2. Trial

    Study registered

    Dec 1, 2024

    Prostate Cancer · RECRUITING · sponsor: Anhui Provincial Hospital · The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate Cancer

    ClinicalTrials.gov · NCT06737588 (opens the source filing in a new tab)

  3. Trial

    PHASE2 registered

    Dec 20, 2023

    Knee Arthroplasty, Total · ACTIVE_NOT_RECRUITING · sponsor: Suzhou Alphamab Co., Ltd. · Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

    ClinicalTrials.gov · NCT06180889 (opens the source filing in a new tab)

  4. Trial

    NA registered

    Sep 1, 2019

    Henoch-Schönlein Purpura · RECRUITING · sponsor: Children's Hospital of Fudan University · Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura

    ClinicalTrials.gov · NCT03647852 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources